Navigation Links
LegalView Reports on Rare Traumatic Brain Injury Condition That Could Cause Complete Paralysis of A Victim
Date:10/30/2008

LegalView recently used its traumatic brain injury blog to report of a severely debilitating condition that can be derived from a brain injury and may cause complete paralysis of a patient. The condition is known as locked-in syndrome, and while it is rare, there is no cure available for current and future victims.

Denver, CO (PRWEB) October 30, 2008 -- LegalView, the number one legal resource available on the Internet, informed its brain injury information blog readers of a severely debilitating condition that has been linked to brain injuries. The condition, known as locked-in syndrome, also called Cerebromedullospinal Disconnection, is considered a rare disease that occurs when the pontine vessels hemorrhage or die, which may caused by a traumatic brain injury (TBI). Unfortunately, there are no known cures for the condition, which causes every muscle in the body to become paralyzed accept for eye movement. Individuals who have suffered from a brain injury should seek medical treatment immediately to avoid the development of such a condition. It is also advisable to locate an experienced traumatic brain injury law firm who can locate a number of brain injury lawyers that can assist in developing potential litigation, which may retrieve monetary compensation for a TBI victim.

There are three classifications of locked-in syndrome, including classic, incomplete, and total. Victims of the condition become quadriplegic and are unable to move their lower face, chew, swallow, speak, breath, move body parts/limbs or move eyes laterally, according to news articles. However, patients are cognitively aware of their surroundings, follow normal sleep cycles and can hear and see. Suffering from a traumatic brain injury disorder can be extremely difficult because of the brain injury symptoms. It is imperative that individuals seek medical attention and possible legal consultation for their injuries. Discussing a potential brain injury lawsuit with a qualified personal injury attorney may offer relief to a brain injured victim and their friends and family.

In addition to a full library of resources for traumatic brain injury patients, LegalView also hosts a number of information portals for victims of other conditions and medical ailments such as the latest scares involving type 2 diabetes medications including Avandia and Byetta, or the most recent treatments being studied for mesothelioma patients.

Both Avandia and Byetta are anti-diabetic prescription drugs that have recently been the subject of investigations by the U.S. Food and Drug Administration (FDA) for serious side effects caused by the drugs. Avandia, from GlaxoSmithKline, has been linked to a list of side effects with the most critical dangers including early on-set osteoporosis and heart failure/disease among Avandia patients. Byetta, also known as exenatide, is manufactured by Amilyn Pharmaceuticals and Eli Lilly and has been causing pancreatic conditions among patients who use the drug, which is given via an injectable pen. According to reports received by the FDA, patients began to be hospitalized for the development of acute pancreatitis only two years after Byetta's approval. Neither Avandia nor Byetta have been recalled, but patients who currently take either drug are encouraged to speak with their medical professional about switching medications. Additionally, it may be important to locate an Avandia lawyer or an experienced Byetta attorney who can support victims of the drug's side effects with the development of a pharmaceutical-based lawsuit. For more information on the drugs, visit the LegalView informational site at http://www.LegalView.com/.

LegalView also continues to update its mesothelioma information portal regularly to provide victims of the damaging cancer with resources for the latest treatments, clinical trials as well as the most recent mesothelioma jury verdicts and how to locate a knowledgeable mesothelioma law firm. Mesothelioma is a rare but deadly form of cancer that is caused through the inhalation of asbestos fibers and dust. Once inhaled, the asbestos fibers begin to form cancerous cells on the lining of the lungs, however, because the condition remains dormant for nearly 20 to 30 years, treating the cancer becomes a difficult feat. It is important for victims of the disease or those who think they may have been exposed to asbestos to consult a medical professional immediately. The sooner the condition is diagnosed, the better the survival rate becomes for a mesothelioma victim.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

###

Read the full story at http://www.prweb.com/releases/2008/10/prweb1546804.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin
2. LegalView Unveils Details of a Breakthrough Mesothelioma Cancer Early Detection Test for Mesothelioma Patients
3. LegalView Brain Injury Site Reports Department of Veteran Affairs Request for Research on TBI and Soldiers
4. LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI
5. LegalView Reports Details of War Veteran Brain Injuries Overlooked By Officials for Years
6. LegalView Warns Proton Pump Inhibitor Patients of Potential Bone Fracture Risk Associated with Drug
7. LegalView Re-launching Truck Accident Injury Information Portal with Updated News and Information on the Costly and Dangerous Accidents
8. LegalView Reports Cancer Risk for St. Louis Residents After Unapproved Asbestos Removal During Demolition
9. LegalView Informs Patients of Possible Cimzia Cancer Link, Drug Commonly Used to Treat Arthritis
10. LegalView Reintroduces its Medical Malpractice Information Portal with Updated Links to Finding Immediate Legal Assistance
11. LegalView Re-Launches its Avandia Information Portal with News of the Type 2 Diabetes Drug's Risks and Dangers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... Aliso Viejo, CA (PRWEB) , ... May 03, 2016 , ... ... use in Final Cut Pro X. Pixel Film Studios’ titles allow users to add ... animations and basic elements such as boxes, lines and accents. To add greater contrast, ...
(Date:5/3/2016)... ... May 03, 2016 , ... Today at its Annual Technology ... D. Pulido, R.Ph., Co-Founder of NCPDP and member of the NCPDP Foundation Board ... IT Specialist, Office of the National Coordinator for Health Information Technology (ONC). NCPDP’s ...
(Date:5/3/2016)... ... ... For over 23 years, Doctors on Liens has committed to ... and therapists treating personal injury patients on a lien basis. With the recent addition ... in Santa Monica, Doctors on Liens is continuing that tradition. While the network ...
(Date:5/3/2016)... ... ... With the opioid epidemic now at the forefront, attention has shifted away from ... its misuse causes long-term consequences for all aspects of society, from the disastrous effects ... and older. In addition, there is the long term affects of chronic liver ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... today announced that it has been honored as one of the nation’s most ... 2016 InformationWeek Elite 100. Horizon received the recognition for technology achievements that have ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... SAN FRANCISCO , May 2, 2016 /PRNewswire/ ...  is expected to reach USD 11.1 billion by ... Grand View Research, Inc. Major drivers of the ... in therapeutic areas and government recommendations for periodic ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ...
(Date:4/29/2016)... , April 29, 2016 ... Review, H1 2016" market research report that provides ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:4/29/2016)... PARIS , April 29, 2016 ... Jérôme Contamine, Directeur Financier ... la santé, publie ses résultats pour ... Financier du Groupe, Jérôme Contamine, commente ... Groupe et les perspectives pour le ...
Breaking Medicine Technology: